Juniper Pharmaceuticals adds director
Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet
Insight Weekly: Stocks limp into 2023; GCC banks set for rebound; deep-sea mining faces pushback
Infographic: The Big Picture 2023 Issuer & Investor Relations Outlook
Infographic: The Big Picture 2023 Sustainability Outlook
Juniper Pharmaceuticals Inc. added Richard Messina to its board.
Messina is the founder, president and CEO of investment banking and financial advisory company The Benchmark Co. LLC.
Boston-based Juniper Pharmaceuticals is a women's health therapeutic company.
